Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Low and High Grade B-Cell Non-Hodgkin Lymphomas

被引：0

作者：

Tian, Xuejun ^{[1
]}

Shahsafaei, Ali ^{[1
]}

Dolfman, David M. ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

来源：

MODERN PATHOLOGY | 2016年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

1493

引用

页码：379A / 379A

页数：1

共 30 条

[1] Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Low and High Grade B-Cell Non-Hodgkin Lymphomas
Tian, Xuejun
Shahsafaei, Ali
Dorfman, David M.
LABORATORY INVESTIGATION, 2016, 96 : 379A - 379A
[2] Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein in Low and High Grade B-Cell Non-Hodgkin Lymphomas and Differential Regulation of EZH2 Expression By p-ERK and MYC in High Grade B Cell Lymphomas
Tian, Xuejun
Shahsafaei, Ali
Dorfman, David M.
BLOOD, 2015, 126 (23)
[3] Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Histiocytic and Dendritic Cell Neoplasms
Tian, Xuejun
Hornick, Jason L.
Fletcher, Christopher
Xu, Jie
Shahsafaei, Ali
Dorfman, David M.
MODERN PATHOLOGY, 2016, 29 : 26A - 26A
[4] Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein and Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Histiocytic and Dendritic Cell Neoplasms
Tian, Xuejun
Hornick, Jason L.
Fletcher, Christopher
Xu, Jie
Shahsafaei, Ali
Dorfman, David M.
LABORATORY INVESTIGATION, 2016, 96 : 26A - 26A
[5] Differential Expression of Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Enhancer of Zeste Homolog 2 (EZH2) Protein-Positive T-Cell Neoplasms
Tian, Xuejun
Shahsafaei, Ali
Pelton, Ashley
Unitt, Christine
Dorfman, David M.
LABORATORY INVESTIGATION, 2017, 97 : 381A - 381A
[6] Differential Expression of Intracellular Signaling Molecules p-ERK, MYC, and p-STAT3 in Enhancer of Zeste Homolog 2 (EZH2) Protein-Positive T-Cell Neoplasms
Tian, Xuejun
Shahsafaei, Ali
Pelton, Ashley
Unitt, Christine
Dorfman, David M.
MODERN PATHOLOGY, 2017, 30 : 381A - 381A
[7] Differential expression of intracellular signaling molecules p-ERK, MYC, and p-STAT3 in enhancer of Zeste Homolog 2 (EZH2) protein-positive T-cell neoplasms.
Tian, Xuejun
Pelton, Ashely K.
Unitt, Christine L.
Dorfman, David M.
CLINICAL CANCER RESEARCH, 2017, 23 (24) : 57 - 58
[8] Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas
Tian, Xuejun
Pelton, Ashley
Shahsafaei, Ali
Dorfman, David M.
MODERN PATHOLOGY, 2016, 29 (09) : 1050 - 1057
[9] Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas
Tian, Xuejun
Xu, Jie
Dorfman, David M.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (01) : 102 - 109
[10] Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling
Tian, Xuejun
Xu, Jie
Fletcher, Christopher
Hornick, Jason L.
Dorfman, David M.
MODERN PATHOLOGY, 2018, 31 (04) : 553 - 561

← 1 2 3 →